首页> 外文期刊>Journal of the American Chemical Society >Site-Directed Conjugation of 'Clicked' Glycopolymers To Form Glycoprotein Mimics: Binding to Mammalian Lectin and Induction of Immunoloaical Function
【24h】

Site-Directed Conjugation of 'Clicked' Glycopolymers To Form Glycoprotein Mimics: Binding to Mammalian Lectin and Induction of Immunoloaical Function

机译:“点击”糖聚合物的定点偶联形成糖蛋白模拟物:与哺乳动物凝集素的结合和免疫功能的诱导

获取原文
获取原文并翻译 | 示例
           

摘要

Synthesis of well-defined neoglycopolymer-protein biohybrid materials and a preliminary study focused on their ability of binding mammalian lectins and inducing immunological function is reported. Crucial intermediates for their preparation are well-defined maleimide-terminated neoglycopolymers (M_n = 8-30 kDa; M_w/M_n= 1.20-1.28) presenting multiple copies of mannose epitope units, obtained by combination of transition-metal-mediated living radical polymerization (TMM LRP) and Huisgen [2+3] cycloaddition. Bovine serum albumin (BSA) was employed as single thiol-containing model protein, and the resulting bioconjugates were purified following two independent protocols and characterized by circular dichroism (CD) spectroscopy, SDS PAGE, and SEC HPLC. The versatility of the synthetic strategy presented in this work was demonstrated by preparing a small library of conjugating glycopolymers that only differ from each other for their relative epitope density were prepared by coclicking of appropriate mixtures of mannopyranoside and galactopyranoside azides to the same polyalkyne scaffold intermediate. Surface plasmon resonance binding studies carried out using recombinant rat mannose-binding lectin (MBL) showed clear and dose-dependent MBL binding to glycopolymer-conjugated BSA. In addition, enzyme-linked immunosorbent assay (ELISA) revealed that the neoglycopolymer-protein materials described in this work possess significantly enhanced capacity to activate complement via the lectin pathway when compared with native unmodified BSA.
机译:报告了定义明确的新糖聚合物蛋白生物杂化材料的合成,并进行了一项初步研究,重点研究了它们结合哺乳动物凝集素和诱导免疫功能的能力。制备它们的关键中间体是定义明确的马来酰亚胺封端的新糖聚合物(M_n = 8-30 kDa; M_w / M_n = 1.20-1.28),具有多种拷贝的甘露糖表位单元,是通过过渡金属介导的活性自由基聚合反应的组合获得的( TMM LRP)和Huisgen [2 + 3]环加成。牛血清白蛋白(BSA)被用作单个含硫醇的模型蛋白,并通过两个独立的方案纯化所得的生物缀合物,并通过圆二色性(CD)光谱,SDS PAGE和SEC HPLC进行表征。通过制备一个小的共轭糖聚合物文库证明了这项工作中提出的合成策略的多功能性,该文库仅通过将甘露吡喃糖苷和吡喃半乳糖苷叠氮化物的适当混合物共点击到同一聚炔骨架中间体上而制备出其相对表位密度彼此不同的共轭糖聚合物。使用重组大鼠甘露糖结合凝集素(MBL)进行的表面等离振子共振结合研究表明,MBL与糖聚合物结合的BSA具有清晰且剂量依赖性。此外,酶联免疫吸附试验(ELISA)显示,与天然未修饰的BSA相比,这项工作中描述的新糖聚合物蛋白材料具有通过凝集素途径激活补体的能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号